Endocrinologists have to step up to the challenge of managing liver disease as a comorbidity in their patients with type 2 diabetes. Speaking at the ADA 2020 virtual Scientific Sessions, Professor Kenneth Cusi said non-alcoholic fatty liver disease (NAFLD) is more common in endocrinology clinics than people realise. While the prevalence of NAFLD as indicated ...
Type 2 diabetes
Call to action on liver disease in T2D
By Mardi Chapman
25 Jun 2020